http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103126993-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d64d39317a5cfb46f5c0bde6569f677a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
filingDate | 2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9363085419c23b548656755814a882e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_904ab195cf0f90cf5e1b7d220ad16342 |
publicationDate | 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103126993-B |
titleOfInvention | Tumor cell active targeting drug delivery system based on nanometer particles and construction method thereof |
abstract | The invention relates to a tumor cell active targeting drug delivery system based on nanometer particles and a construction method thereof. The tumor cell active targeting drug delivery system is characterized by using the nanometer particles with photocatalytic performance as carriers to obtain targeted molecule/nanometer particle/chemotherapy drug compounds in a physical absorption or chemical bonding mode, the mole ratio of the nanometer particles and targeted molecules is 50:1-20:1, the mole ratio of the nanometer particles and chemotherapy drugs is 50:1-10:1. The tumor cell active targeting drug delivery system integrates the chemotherapy drugs, the targeted molecules and the nanometers particles with photocatalytic performance, enables a nanometer particle dry carrying system to have active tumor cell targeting capacity, effectively reduces side effects of the chemotherapy drugs, can realize controllable release of the chemotherapy drug and reverse multiple drug resistance of the tumor cell, and is simple and easy in construction method, low in cost, and favorable to industrialized production and market popularization. |
priorityDate | 2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.